These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38666319)

  • 1. Association of cardiac biomarkers with long-term cardiovascular events in a community cohort.
    Churchill RA; Gochanour BR; Scott CG; Vasile VC; Rodeheffer RJ; Meeusen JW; Jaffe AS
    Biomarkers; 2024 Jun; 29(4):161-170. PubMed ID: 38666319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker-based risk prediction in the community.
    AbouEzzeddine OF; McKie PM; Scott CG; Rodeheffer RJ; Chen HH; Michael Felker G; Jaffe AS; Burnett JC; Redfield MM
    Eur J Heart Fail; 2016 Nov; 18(11):1342-1350. PubMed ID: 27813304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Sensitivity Cardiac Troponin-T and N-Terminal Prohormone of B-Type Natriuretic Peptide in Relation to Cardiovascular Outcomes in Type 1 Diabetes.
    Costacou T; Saenger AK; Orchard TJ
    Diabetes Care; 2020 Sep; 43(9):2199-2207. PubMed ID: 32616616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma Ceramides.
    Meeusen JW; Donato LJ; Bryant SC; Baudhuin LM; Berger PB; Jaffe AS
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1933-1939. PubMed ID: 29903731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptides for the prediction of cardiovascular events in patients with stable coronary heart disease: the Heart and Soul Study.
    Mishra RK; Beatty AL; Jaganath R; Regan M; Wu AH; Whooley MA
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25053234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.
    Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F
    Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men.
    Skoglund PH; Höijer J; Ärnlöv J; Zethelius B; Svensson P
    Hypertension; 2015 Sep; 66(3):681-6; discussion 445. PubMed ID: 26150437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation.
    Wöhrle J; Karakas M; Trepte U; Seeger J; Gonska B; Koenig W; Rottbauer W
    PLoS One; 2015; 10(9):e0137464. PubMed ID: 26368980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
    Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
    Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.
    Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Ezekowitz MD; Hohnloser SH; Reilly PA; Vinereanu D; Siegbahn A; Yusuf S; Wallentin L
    Circulation; 2012 Apr; 125(13):1605-16. PubMed ID: 22374183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
    Bai J; Han L; Liu H
    Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Risk Assessment Tool Incorporating New Biomarkers for Cardiovascular Events in Acute Coronary Syndromes: The Organization to Assess Strategies in Ischemic Syndromes (OASIS) Risk Score.
    Mehta SR; Eikelboom JW; Rao-Melacini P; Weitz JI; Anand SS; Pare G; Budaj A; Pogue J; Fox KA; Yusuf S
    Can J Cardiol; 2016 Nov; 32(11):1332-1339. PubMed ID: 27062239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery.
    Polineni S; Parker DM; Alam SS; Thiessen-Philbrook H; McArthur E; DiScipio AW; Malenka DJ; Parikh CR; Garg AX; Brown JR
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.
    Sabatine MS; Morrow DA; Higgins LJ; MacGillivray C; Guo W; Bode C; Rifai N; Cannon CP; Gerszten RE; Lee RT
    Circulation; 2008 Apr; 117(15):1936-44. PubMed ID: 18378613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease.
    Dai DF; Hwang JJ; Lin JL; Lin JW; Hsu CN; Lin CM; Chiang FT; Lai LP; Hsu KL; Tseng CD; Tseng YZ
    Circ J; 2008 Aug; 72(8):1316-23. PubMed ID: 18654020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of cumulative atherogenic index of plasma (AIP) for cardiovascular outcomes: a prospective community-based cohort study.
    Liu Z; Zhang L; Wang L; Li K; Fan F; Jia J; Li J; Zhang Y
    Cardiovasc Diabetol; 2024 Jul; 23(1):264. PubMed ID: 39026310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.